Literature DB >> 25433310

T cell responses in hepatitis C virus infection: historical overview and goals for future research.

Lauren Holz1, Barbara Rehermann2.   

Abstract

Hepatitis C virus (HCV)-specific T cells are key factors in the outcome of acute HCV infection and in protective immunity. This review recapitulates the steps that immunologists have taken in the past 25years to dissect the role of T cell responses in HCV infection. It describes technical as well as disease-specific challenges that were caused by the inapparent onset of acute HCV infection, the difficulty to identify subjects who spontaneously clear HCV infection, the low frequency of HCV-specific T cells in the blood of chronically infected patients, and the lack of small animal models with intact immune systems to study virus-host interaction. The review provides a historical perspective on techniques and key findings, and identifies areas for future research. Published by Elsevier B.V.

Entities:  

Keywords:  Hepatitis C virus; History; Immunological techniques; Infection; T cell

Mesh:

Substances:

Year:  2014        PMID: 25433310      PMCID: PMC4480227          DOI: 10.1016/j.antiviral.2014.11.009

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  102 in total

1.  Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.

Authors:  Cheryl L Day; Nilufer P Seth; Michaela Lucas; Heiner Appel; Laurent Gauthier; Georg M Lauer; Gregory K Robbins; Zbigniew M Szczepiorkowski; Deborah R Casson; Raymond T Chung; Shannon Bell; Gillian Harcourt; Bruce D Walker; Paul Klenerman; Kai W Wucherpfennig
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

2.  Hepatitis C virus mutation affects proteasomal epitope processing.

Authors:  Ulrike Seifert; Heike Liermann; Vito Racanelli; Anne Halenius; Manfred Wiese; Heiner Wedemeyer; Thomas Ruppert; Kay Rispeter; Peter Henklein; Alice Sijts; Hartmut Hengel; Peter-M Kloetzel; Barbara Rehermann
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

3.  Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.

Authors:  Birke Bartosch; Alessandra Vitelli; Christelle Granier; Caroline Goujon; Jean Dubuisson; Simona Pascale; Elisa Scarselli; Riccardo Cortese; Alfredo Nicosia; François-Loïc Cosset
Journal:  J Biol Chem       Date:  2003-08-11       Impact factor: 5.157

4.  Cross-genotype immunity to hepatitis C virus.

Authors:  Robert E Lanford; Bernadette Guerra; Deborah Chavez; Catherine Bigger; Kathleen M Brasky; Xiao-Hong Wang; Stuart C Ray; David L Thomas
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  HCV persistence and immune evasion in the absence of memory T cell help.

Authors:  Arash Grakoui; Naglaa H Shoukry; David J Woollard; Jin-Hwan Han; Holly L Hanson; John Ghrayeb; Krishna K Murthy; Charles M Rice; Christopher M Walker
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

6.  Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source.

Authors:  Susan M McKiernan; Richard Hagan; Michael Curry; George S A McDonald; Alan Kelly; Niamh Nolan; Anne Walsh; John Hegarty; Emer Lawlor; Dermot Kelleher
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

7.  Advantage of rare HLA supertype in HIV disease progression.

Authors:  Elizabeth Trachtenberg; Bette Korber; Cristina Sollars; Thomas B Kepler; Peter T Hraber; Elizabeth Hayes; Robert Funkhouser; Michael Fugate; James Theiler; Yen S Hsu; Kevin Kunstman; Samuel Wu; John Phair; Henry Erlich; Steven Wolinsky
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

8.  Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution.

Authors:  Joerg Timm; Bin Li; Marcus G Daniels; Tanmoy Bhattacharya; Laura L Reyor; Rachel Allgaier; Thomas Kuntzen; Will Fischer; Brian E Nolan; Jared Duncan; Julian Schulze zur Wiesch; Arthur Y Kim; Nicole Frahm; Christian Brander; Raymond T Chung; Georg M Lauer; Bette T Korber; Todd M Allen
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

9.  Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection.

Authors:  Kazushi Sugimoto; Fusao Ikeda; Jason Stadanlick; Frederick A Nunes; Harvey J Alter; Kyong-Mi Chang
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

10.  Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection.

Authors:  Michaela Lucas; Axel Ulsenheimer; Katja Pfafferot; Malte H J Heeg; Silvana Gaudieri; Norbert Grüner; Andri Rauch; J Tilman Gerlach; Maria-Christina Jung; Reinhart Zachoval; Gerd R Pape; Winfried Schraut; Teresa Santantonio; Hans Nitschko; Martin Obermeier; Rodney Phillips; Thomas J Scriba; Nasser Semmo; Cheryl Day; Jonathan N Weber; Sarah Fidler; Robert Thimme; Anita Haberstroh; Thomas F Baumert; Paul Klenerman; Helmut M Diepolder
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

View more
  25 in total

1.  Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.

Authors:  María Q Marín; Patricia Pérez; Karl Ljungberg; Carlos Óscar S Sorzano; Carmen E Gómez; Peter Liljeström; Mariano Esteban; Juan García-Arriaza
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

Review 2.  Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.

Authors:  R Servín-Blanco; R Zamora-Alvarado; G Gevorkian; K Manoutcharian
Journal:  Hum Vaccin Immunother       Date:  2016-06-13       Impact factor: 3.452

Review 3.  Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.

Authors:  L B Dustin; B Bartolini; M R Capobianchi; M Pistello
Journal:  Clin Microbiol Infect       Date:  2016-08-31       Impact factor: 8.067

Review 4.  Designing an HCV vaccine: a unique convergence of prevention and therapy?

Authors:  Christopher M Walker
Journal:  Curr Opin Virol       Date:  2017-05-25       Impact factor: 7.090

5.  A rational mouse model to detect on-target, off-tumor CAR T cell toxicity.

Authors:  Mauro Castellarin; Caroline Sands; Tong Da; John Scholler; Kathleen Graham; Elizabeth Buza; Joseph A Fraietta; Yangbing Zhao; Carl H June
Journal:  JCI Insight       Date:  2020-07-23

Review 6.  Addressing the next challenges: A summary of the 22nd international symposium on hepatitis C virus and related viruses.

Authors:  Thomas F Baumert; Catherine Schuster; François-Loïc Cosset; Jean Dubuisson; Maike Hofmann; Norbert Tautz; Mirjam B Zeisel; Robert Thimme
Journal:  J Hepatol       Date:  2016-01-11       Impact factor: 30.083

Review 7.  Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants.

Authors:  Marie-Ève Lebel; Karine Chartrand; Denis Leclerc; Alain Lamarre
Journal:  Vaccines (Basel)       Date:  2015-08-05

Review 8.  Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies.

Authors:  Catherine Fauvelle; Che C Colpitts; Zhen-Yong Keck; Brian G Pierce; Steven K H Foung; Thomas F Baumert
Journal:  Expert Rev Vaccines       Date:  2016-06-13       Impact factor: 5.683

Review 9.  Adaptive immunity in the liver.

Authors:  Zongwen Shuai; Miranda Wy Leung; Xiaosong He; Weici Zhang; Guoxiang Yang; Patrick Sc Leung; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2016-03-21       Impact factor: 11.530

10.  Effect of adefovir dipivoxil on T cell immune function in the treatment of chronic hepatitis B and hepatocirrhosis.

Authors:  Liting Tian; Qilin Fu; Fu Huang
Journal:  Exp Ther Med       Date:  2016-08-29       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.